Lichen sclerosus
ICD-10 L90.0 · ICD-11 EB60

Genital Lichen Sclerosus in Boys Under 18 Years

This protocol covers male paediatric patients (under 18 years) presenting with genital lichen sclerosus. Age and sex are both clinically relevant in shaping the recommended management path for this population.

Ultrapotent or potent topical corticosteroids are recommended as the primary intervention in boys with genital lichen sclerosus.

When initial medical management is insufficient, the protocol addresses specific anatomical presentations that may warrant a surgical approach. The selection between procedures depends on the presenting features — the full decision algorithm and supporting evidence are available in the structured regimen.

Surgical intervention is included in this protocol for select presentations … the full criteria and procedure details are in the structured regimen.

Remission with no signs of recurrence
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jdv.20083

We recommend ultrapotent or potent topical corticosteroids in boys with genital lichen sclerosus.

We suggest circumcision, preferably removing the complete foreskin if guideline-conform treatment with e.g. steroids in boys with phimosis caused by lichen sclerosus fails.

We suggest frenuloplasty in combination with intralesional triamcinolone, or alternatively, a complete circumcision if guideline-conform treatment with e.g. steroids fails in boys with scarring or shortening of the frenulum caused by lichen sclerosus.

In a prospective study, 10 boys with LS were clinically controlled 5 years after surgery and showed no signs of recurrence.

View source ↗